Lv2
180 积分 2026-05-07 加入
Efficacy and safety of dabrafenib plus trametinib in adults with differentiated thyroid cancer: a randomised, double-blind, placebo-controlled, phase 3 trial
1个月前
已完结
Anlotinib Plus Sintilimab for BRAF V600E Negative Unresectable or Metastatic Anaplastic Thyroid Carcinoma: A Single-Center, Single-Arm, Phase 2 Trial
1个月前
已完结
局部晚期甲状腺癌安罗替尼靶向新辅助治疗的真实世界研究
1个月前
已完结
2024 American College of Rheumatology (ACR) Guideline for the Screening, Treatment, and Management of Lupus Nephritis
3个月前
已完结
皖公网安备34019202002308
